93 related articles for article (PubMed ID: 19875195)
1. Urocortin modulates dopaminergic neuronal survival via inhibition of glycogen synthase kinase-3β and histone deacetylase.
Huang HY; Lin SZ; Chen WF; Li KW; Kuo JS; Wang MJ
Neurobiol Aging; 2011 Sep; 32(9):1662-77. PubMed ID: 19875195
[TBL] [Abstract][Full Text] [Related]
2. Urocortin modulates inflammatory response and neurotoxicity induced by microglial activation.
Wang MJ; Lin SZ; Kuo JS; Huang HY; Tzeng SF; Liao CH; Chen DC; Chen WF
J Immunol; 2007 Nov; 179(9):6204-14. PubMed ID: 17947696
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation contributes to urocortin-enhanced midbrain dopaminergic neuron differentiation.
Huang HY; Chiu TL; Chang HF; Hsu HR; Pang CY; Liew HK; Wang MJ
Stem Cells; 2015 May; 33(5):1601-17. PubMed ID: 25641682
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibition mediates urocortin-induced antiproliferation and neuronal differentiation in neural stem cells.
Huang HY; Liu DD; Chang HF; Chen WF; Hsu HR; Kuo JS; Wang MJ
Stem Cells; 2012 Dec; 30(12):2760-73. PubMed ID: 22961741
[TBL] [Abstract][Full Text] [Related]
5. Urocortin-induced cardiomyocytes hypertrophy is associated with regulation of the GSK-3β pathway.
Gruson D; Ginion A; Decroly N; Lause P; Vanoverschelde JL; Ketelslegers JM; Bertrand L; Thissen JP
Heart Vessels; 2012 Mar; 27(2):202-7. PubMed ID: 21505854
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease.
Golpich M; Amini E; Hemmati F; Ibrahim NM; Rahmani B; Mohamed Z; Raymond AA; Dargahi L; Ghasemi R; Ahmadiani A
Pharmacol Res; 2015 Jul; 97():16-26. PubMed ID: 25829335
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
Koh SH; Noh MY; Kim SH
Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
[TBL] [Abstract][Full Text] [Related]
8. Activation of Akt/GSK-3beta/beta-catenin signaling pathway is involved in survival of neurons after traumatic brain injury in rats.
Zhao S; Fu J; Liu X; Wang T; Zhang J; Zhao Y
Neurol Res; 2012 May; 34(4):400-7. PubMed ID: 22643085
[TBL] [Abstract][Full Text] [Related]
9. GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons.
Castelo-Branco G; Rawal N; Arenas E
J Cell Sci; 2004 Nov; 117(Pt 24):5731-7. PubMed ID: 15522889
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of urocortin on 1-methyl-4-phenylpyridinium-induced dopaminergic neuronal death.
Kim Y; Park MK; Chung S
Mol Cells; 2010 Nov; 30(5):427-33. PubMed ID: 20821057
[TBL] [Abstract][Full Text] [Related]
11. The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.
Hongisto V; Vainio JC; Thompson R; Courtney MJ; Coffey ET
Mol Cell Biol; 2008 Mar; 28(5):1515-27. PubMed ID: 18195042
[TBL] [Abstract][Full Text] [Related]
12. Association of glycogen synthase kinase-3β with Parkinson's disease (review).
Li DW; Liu ZQ; Chen W; Yao M; Li GR
Mol Med Rep; 2014 Jun; 9(6):2043-50. PubMed ID: 24681994
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing hormone and urocortin promote phagocytosis of rat macrophages through convergent but distinct pathways.
Wang WC; Zhang XZ; Liu DW; Qiu J; Wang XH; Zhou JH
Life Sci; 2015 Feb; 122():100-7. PubMed ID: 25534437
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
Wang HM; Zhang T; Li Q; Huang JK; Chen RF; Sun XJ
Neurochem Int; 2013 Nov; 63(5):345-53. PubMed ID: 23871716
[TBL] [Abstract][Full Text] [Related]
15. The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotection.
Espada S; Rojo AI; Salinas M; Cuadrado A
J Neurochem; 2009 Aug; 110(3):1107-19. PubMed ID: 19558456
[TBL] [Abstract][Full Text] [Related]
16. Sirtuin 2 enhances dopaminergic differentiation via the AKT/GSK-3β/β-catenin pathway.
Szegő ÉM; Gerhardt E; Outeiro TF
Neurobiol Aging; 2017 Aug; 56():7-16. PubMed ID: 28478325
[TBL] [Abstract][Full Text] [Related]
17. Glial cell line-derived neurotrophic factor-mediated enteric neuronal survival involves glycogen synthase kinase-3beta phosphorylation and coupling with 14-3-3.
Mwangi S; Anitha M; Fu H; Sitaraman SV; Srinivasan S
Neuroscience; 2006 Nov; 143(1):241-51. PubMed ID: 16996218
[TBL] [Abstract][Full Text] [Related]
18. Urocortin, a CRF-like peptide, restores key indicators of damage in the substantia nigra in a neuroinflammatory model of Parkinson's disease.
Abuirmeileh A; Harkavyi A; Lever R; Biggs CS; Whitton PS
J Neuroinflammation; 2007 Jul; 4():19. PubMed ID: 17659087
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3beta activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells.
Lee KY; Koh SH; Noh MY; Park KW; Lee YJ; Kim SH
Brain Res; 2007 Jan; 1129(1):89-99. PubMed ID: 17157278
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of atypical D1 receptor agonist SKF83959 are mediated via D1 receptor-dependent inhibition of glycogen synthase kinase-3 beta and a receptor-independent anti-oxidative action.
Yu Y; Wang JR; Sun PH; Guo Y; Zhang ZJ; Jin GZ; Zhen X
J Neurochem; 2008 Feb; 104(4):946-56. PubMed ID: 18005341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
